Achieve Life Sciences, Inc. (ACHV) is a publicly traded Healthcare sector company. As of May 19, 2026, ACHV trades at $4.47 with a market cap of $543.07M and a P/E ratio of -3.61. ACHV moved -6.08% today. Year to date, ACHV is -4.02%; over the trailing twelve months it is +54.87%. Its 52-week range spans $1.84 to $6.15. Analyst consensus is strong buy with an average price target of $13.20. Rallies surfaces ACHV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Achieve Life Sciences, Inc. (ACHV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ACHV moved -6.08% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $4.47 |
| Market Cap | $543.07M |
| P/E Ratio | -3.61 |
| EPS | $-1.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.15 |
| 52-Week Low | $1.84 |
| Volume | 1.18M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-54.65M |
| Gross Margin | 0.00% |
5 analysts cover ACHV: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.20.